Colm A. O’morain
#116,089
Most Influential Person Now
Colm A. O’morain's AcademicInfluence.com Rankings
Colm A. O’morainphilosophy Degrees
Philosophy
#5046
World Rank
#7758
Historical Rank
Logic
#2387
World Rank
#3371
Historical Rank

Download Badge
Philosophy
Colm A. O’morain's Degrees
- Masters Medicine National University of Ireland
- Doctorate Medicine National University of Ireland
Why Is Colm A. O’morain Influential?
(Suggest an Edit or Addition)Colm A. O’morain's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease (2001) (5565)
- Helicobacter pylori Infection (1994) (2472)
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report (2006) (2333)
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (2012) (2271)
- Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (2016) (2261)
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. (2010) (1578)
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report (2002) (1309)
- CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. (2002) (996)
- Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). (1997) (898)
- Newly identified genetic risk variants for celiac disease related to the immune response (2008) (697)
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study (1996) (562)
- CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY (1987) (537)
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2011) (533)
- Geographical variability and environmental risk factors in inflammatory bowel disease (2013) (469)
- European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations (2006) (449)
- Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. (1998) (424)
- The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. (1999) (414)
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2012) (374)
- Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay (1999) (344)
- Treatment of Helicobacter pylori (1998) (288)
- Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study (1999) (280)
- Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. (2000) (262)
- Absorption of 151chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease (1983) (253)
- Treatment of Helicobacter pylori Infection (2006) (240)
- E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach (2010) (235)
- Sequential Therapy for Helicobacter pylori Eradication: A Critical Review (2010) (223)
- Nature meets nurture: molecular genetics of gastric cancer (2009) (220)
- Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. (2006) (219)
- Reversible male infertility due to sulphasalazine: studies in man and rat. (1984) (208)
- One week triple therapy for Helicobacter pylori: a multicentre comparative study (1997) (191)
- Review article: defining remission in ulcerative colitis (2011) (190)
- Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease (2011) (182)
- Does Pregnancy Change the Disease Course? A Study in a European Cohort of Patients with Inflammatory Bowel Disease (2006) (181)
- Review article: the long‐term use of proton‐pump inhibitors (2005) (174)
- Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
- Criteria of case definition in Crohn's disease and ulcerative colitis. (1989) (163)
- The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. (2006) (161)
- Validation of the Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI or Niv score): a multicenter prospective study (2011) (152)
- Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. (1999) (152)
- Colorectal Adenoma Characteristics as Predictors of Recurrence (2004) (141)
- Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding (2000) (140)
- Population screening and treatment of Helicobacter pylori infection (2017) (138)
- Review article: nutrition and adult inflammatory bowel disease. (2003) (128)
- Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. (1996) (127)
- The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer (1999) (127)
- Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort (2005) (125)
- High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. (2013) (125)
- Public awareness of risk factors and screening for colorectal cancer in Europe (2004) (123)
- Current therapeutic options for gastric antral vascular ectasia (2003) (123)
- Treatment of Helicobacter pylori Infection (2008) (121)
- Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study (2000) (119)
- Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. (1997) (118)
- Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. (2014) (115)
- Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022) (115)
- Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia (1998) (113)
- Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. (1991) (109)
- Efficacy and safety of single‐triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study (2003) (108)
- Rifabutin‐ and furazolidone‐based Helicobacter pylori eradication therapies after failure of standard first‐ and second‐line eradication attempts in dyspepsia patients (2005) (108)
- Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (106)
- Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. (2012) (103)
- European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients (2020) (98)
- Helicobacter pylori and duodenal ulcer recurrence. (1992) (96)
- Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. (1990) (95)
- Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. (1996) (94)
- Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. (1984) (94)
- Treatment of Helicobacter pylori infection and factors influencing eradication (2002) (93)
- Development of an index to define overall disease severity in IBD (2016) (92)
- Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. (1996) (92)
- The prevalence of genetic and serologic markers in an unselected European population‐based cohort of IBD patients (2007) (91)
- Diagnosis of gluten‐sensitive enteropathy: is exclusive reliance on histology appropriate? (1998) (88)
- Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study. (2014) (87)
- Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort (2014) (87)
- Disease outcome of inflammatory bowel disease patients: General outline of a Europe-wide population-based 10-year clinical follow-up study (2006) (85)
- Association of NOD2 with Crohn's Disease in a homogenous Irish population (2003) (84)
- Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori (1994) (83)
- Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (82)
- Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. (1995) (81)
- The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis (2015) (81)
- Patient knowledge and educational needs in irritable bowel syndrome (2000) (79)
- Recurrence of Helicobacter pylori Infection After Successful Eradication (Nature and Possible Causes) (1997) (77)
- Treatment of Helicobacter pylori Infection 2010 (2010) (77)
- Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study (2015) (75)
- Argon plasma coagulation as first‐line treatment for chronic radiation proctopathy (2004) (73)
- Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology (2014) (71)
- Review: Improving compliance with Helicobacter pylori eradication therapy: when and how? (2009) (71)
- Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. (1988) (71)
- Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. (1997) (69)
- IBD patients need in health quality of care ECCO consensus. (2008) (67)
- Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. (1993) (67)
- Nutrition in inflammatory bowel disease. (2006) (65)
- Genomic DNA fingerprinting of clinical isolates of Helicobacter pylori using short oligonucleotide probes containing repetitive sequences. (1996) (63)
- CARD4/NOD1 is not involved in inflammatory bowel disease (2003) (62)
- Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: a Network Meta-Analysis. (2021) (61)
- Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. (2003) (61)
- Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis (2004) (59)
- Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection (1997) (59)
- Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients. (2019) (58)
- Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis (1991) (57)
- Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn’s Disease in Clinical Remission (2015) (56)
- Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy. (1988) (55)
- Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer (1993) (55)
- Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study (2015) (55)
- Does cure of Helicobacter pylori infection induce heartburn (1998) (54)
- Long-term prospective study ofHelicobacter pylori in nonulcer dyspepsia (2005) (53)
- Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer (1994) (53)
- Therapy of Helicobacter pylori (2004) (53)
- Current Concepts and Management (2000) (53)
- Nutritional Therapy in Crohn's Disease (1998) (53)
- Metronidazole Resistance Reduces Efficacy of Triple Therapy and Leads to Secondary Clarithromycin Resistance (1997) (52)
- A validated dyspepsia symptom score. (1997) (52)
- Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. (1983) (51)
- Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. (1986) (50)
- Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study (2001) (50)
- Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. (1995) (50)
- Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study. (2014) (49)
- Treatment of Helicobacter pylori Infection 2013 (2013) (49)
- Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception (2008) (48)
- A community‐based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology (1998) (48)
- United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia (2021) (47)
- Treatment of Helicobacter pylori Infection 2011 (2011) (47)
- Omeprazole increases permeability across isolated rat gastric mucosa pre‐treated with an acid secretagogue (2002) (47)
- The effect of bile acids on the growth and adherence of Helicobacter pylori (1991) (46)
- Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland (2010) (46)
- Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates. (1999) (45)
- Isolated Active Ileitis: Is It a Mild Subtype of Crohn's Disease? (2013) (45)
- Treatment of Helicobacter pylori infection 2012 (2012) (45)
- Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4 (2009) (44)
- Review: Treatment of Helicobacter pylori Infection 2019 (2019) (44)
- Treatment of Helicobacter pylori infection in 2018 (2018) (42)
- Epithelial patchy necrosis in Crohn's disease. (1983) (42)
- Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case–control study (2011) (41)
- Coeliac disease in Europe (2003) (41)
- Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. (1997) (40)
- Prevalence of metronidazole-resistant helicobacter pylori in dyspeptic patients (1993) (40)
- Prevalence of Helicobacter pylori in non-ulcer dyspepsia. (1995) (40)
- Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. (1995) (39)
- Eradication of Helicobacter pylori: recent advances in treatment (2005) (39)
- Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population (2006) (39)
- Pre-formed urease activity of Helicobacter pylori as determined by a viable cell count technique--clinical implications. (1994) (37)
- Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg) (2019) (37)
- Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? (2009) (36)
- Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. (1993) (36)
- Helicobacter biology--discovery. (1998) (35)
- Short report: treatment of Helicobacter pylori‐associated duodenal ulcer with omeprazole plus antibiotics (1993) (35)
- Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1. (2005) (35)
- Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples (2016) (35)
- Therapeutic benefits of budesonide in gastroenterology (2010) (34)
- Enhanced cultivation of Helicobacter pylori in liquid media. (1993) (34)
- Helicobacter pylori Gastritis, the Unifying Concept for Gastric Diseases (2007) (33)
- Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates. (2005) (33)
- A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection (2019) (33)
- Vitamin D status and cytokine levels in patients with Crohn's disease. (2011) (32)
- Treatment of Helicobacter pylori Infection 2015 (2015) (32)
- European Crohn’s and Colitis Organisation Topical Review on Environmental Factors in IBD (2016) (32)
- Effect of oral calcium supplementation on colonie crypt cell proliferation in patients with adenomatous polyps of the large bowel (1993) (32)
- Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5‐Year Follow‐Up Study (2002) (31)
- Nutritional Therapy in Inflammatory Bowel Disease. (2004) (30)
- Identification of genes regulated by prolonged acid exposure in Helicobacter pylori. (2001) (30)
- Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. (2013) (30)
- Treatment of Helicobacter pylori infection 2017 (2017) (30)
- Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght–Trinity College colorectal cancer screening programme with the faecal immunological test (2014) (30)
- Barrett's esophagus and the presence of Helicobacter pylori. (1998) (29)
- Nutritional therapy in inflammatory bowel diseas (2004) (29)
- Safety of infliximab in 10 years of clinical practice (2011) (29)
- Different management of Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease (1998) (28)
- Digestive Function of the Stomach (2014) (28)
- Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis. (2008) (28)
- Effects of Smoking on Cure of Helicobacter pylori Infection and Duodenal Uulcer Recurrence in Patients Treated with Clarithromycin and Omeprazole (1997) (28)
- Erythrocyte Mean Corpuscular Volume (MCV) Correlation with Thiopurine Methyl Transferase (TPMT) Activity in Inflammatory Bowel Disease (IBD) Patients Receiving Azathioprine (AZA)/6-Mercaptopurine (6MP) (2004) (27)
- Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD. (2021) (27)
- Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease. (1985) (27)
- Helicobacter Pylori: The Cancer Link (1996) (27)
- Short report: high‐dose omeprazole and amoxycillin in the treatment of Helicobacter pylori‐associated duodenal ulcer (1993) (27)
- European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice (2020) (26)
- Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease (2007) (26)
- Treatment of Helicobacter pylori Infection 2014 (2014) (26)
- Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations. (1984) (26)
- Clinical and economic outcomes in a population‐based European cohort of 948 ulcerative colitis and Crohn’s disease patients by Markov analysis (2009) (25)
- Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II. (2009) (25)
- Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci (2015) (25)
- Vitamin D: new roles and therapeutic potential in inflammatory bowel disease. (2012) (25)
- Pylera® for the eradication of Helicobacter pylori infection (2009) (25)
- Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice (2000) (25)
- The sequential therapy regimen for Helicobacter pylori eradication (2010) (25)
- Double‐blind, Multicenter, Placebo‐Controlled Evaluation Of Clarithromycin And Omeprazole For Helicobacter Pylori‐Associated Duodenal Ulcer (1996) (25)
- Short report: short‐term triple therapy for H. pylori‐associated duodenal ulcer disease (1992) (25)
- Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg). (2021) (24)
- Recommendations for a step‐wise comparative approach to the evaluation of new screening tests for colorectal cancer (2016) (24)
- Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study. (2014) (24)
- The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori (1996) (24)
- Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. (2007) (24)
- [European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]. (2019) (24)
- Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) (2021) (24)
- Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection? (2018) (23)
- [Gastric cancer: a long-term consequence of Helicobacter pylori infection?]. (1994) (23)
- A historical perspective of Helicobacter gastroduodenitis and its complications. (2007) (23)
- Challenges to Therapy in the Future (2000) (23)
- Pathogenesis and host response in helicobacter pylori infections (1997) (23)
- Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi‐centre study using centralized facility testing (2000) (23)
- Helicobacter pylori first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp‐EuReg) (2020) (23)
- Nonulcer dyspepsia. Current concepts and management. (2000) (22)
- Noninvasive Diagnosis of Helicobacter pylori Infection: A Review (1997) (22)
- Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease (2007) (22)
- Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study (2017) (22)
- Helicobacter pylori infection in elderly dyspeptic patients. (1991) (22)
- The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease (2010) (22)
- New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report. (1998) (22)
- Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma (2007) (22)
- Practical treatment of Helicobacter pylori: a balanced view in changing times (2014) (22)
- Gastro-oesophageal reflux disease andHelicobacter pylori: an intricate relation (1999) (21)
- Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? (1990) (21)
- Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006. (2007) (21)
- HpSA: Assessment of a new non-invasive diagnostic assay for helicobacter pylori infection in an Irish population (1999) (21)
- Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort. (2008) (21)
- Helicobacter pylori resistance to current therapies (2019) (21)
- Review – Treatment of Helicobacter pylori infection 2020 (2020) (21)
- Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study (2018) (21)
- Treatment inferred disease severity in Crohn's disease: Evidence for a European gradient of disease course (2007) (20)
- Genotyping of cagA and vacA, Lewis antigen status, and analysis of the poly-(C) tract in the alpha(1,3)-fucosyltransferase gene of Irish Helicobacter pylori isolates. (2000) (20)
- Carditis: All Helicobacter pylori or Is There a Role for Gastro-oesophageal Reflux? (2002) (20)
- Sunshine is an Important Determinant of Vitamin D Status Even Among High‐dose Supplement Users: Secondary Analysis of a Randomized Controlled Trial in Crohn's Disease Patients (2019) (20)
- Helicobacter pylori and dyspepsia. (1996) (20)
- A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients (2016) (20)
- Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease. (1983) (20)
- Elemental diets in the treatment of Crohn's disease (1979) (20)
- Helicobacter pylori and gastric cancer. (1995) (20)
- Barrett's Esophagus and the Presence of Helicobacter pylori (1998) (19)
- Determination of the optimal transport system for Helicobacter pylori cultures. (1993) (19)
- Yersinia frederiksenii infection and colonization in hospital staff. (1993) (19)
- Trends in the management of gastro-oesophageal reflux disease. (1998) (19)
- Colorectal cancer screening. (2006) (19)
- Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 8th ed. Pathophysiology/Diagnosis/Management. (2007) (18)
- Haplotype variation at the IBD5/SLC22A4 locus (5q31) in coeliac disease in the Irish population. (2004) (18)
- In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. (2006) (18)
- Helicobacter pylori infection in Europe: current perspectives (2013) (18)
- The long-term effect of Helicobacter pylori on gastric mucosa (1994) (17)
- Helicobacter pylori eradication--a surrogate marker for duodenal ulcer healing. (1996) (17)
- The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. (2017) (17)
- DOP001 European Crohn's and Colitis Organisation topical review on environmental factors in IBD. (2017) (17)
- Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). (2005) (17)
- Helicobacter pylori eradication: role of individual therapy constituents and therapy duration (2009) (16)
- Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease (2015) (16)
- United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia (2021) (16)
- Room for Improvement in the Treatment of Helicobacter pylori Infection (2021) (16)
- Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease. (2013) (16)
- Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland (2010) (15)
- Transportation of Helicobacter pylori cultures by optimal systems (1994) (15)
- Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg) (2020) (15)
- [European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers]. (2016) (15)
- Primary prevention of colorectal cancer: are we closer to reality? (2010) (15)
- A randomized–controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population (2015) (15)
- Role of Helicobacter pylori in functional dyspepsia. (2006) (15)
- Statistical annex: statistical aspects of clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (15)
- Culture ofHelicobacter pylori under aerobic conditions on solid media (1994) (14)
- Consensus guidelines: agreement and debate surrounding the optimal management of Helicobacter pylori infection. (2000) (14)
- CARD 4 / NOD 1 is not involved in inflammatory bowel disease (2002) (14)
- Novel celiac disease genetic determinants related to the immune response (2009) (14)
- Screening for colorectal cancer: what fits best? (2012) (14)
- Effect of eradication ofHelicobacter pylori infection on gastric epithelial cell proliferation (1995) (14)
- The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. (2017) (14)
- Fish Oil in the Treatment of Ulcerative Colitis (1990) (14)
- The ECP calcium fibre polyp prevention study preliminary report. ECP Colon Group. (1993) (14)
- The long-term use of proton-pump inhibitors (2005) (14)
- Temporomandibular joint dislocation: an unusual complication of upper gastrointestinal endoscopy (2000) (13)
- Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori. (2004) (13)
- Treatment of Helicobacter pylori infection 2016 (2016) (13)
- Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate. (2004) (13)
- Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection? (2009) (13)
- Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort (2014) (12)
- What is new in the management of Helicobacter pylori? (2008) (12)
- Patient knowledge in inflammatory bowel disease (2000) (12)
- Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management (2017) (12)
- Dietary Antigens in Crohn's Disease: Antibodies to Porcine Pancreatic Amylase (2008) (12)
- Impact of Helicobacter pylori on the management of dyspepsia in primary care (2006) (12)
- Aspirin as a chemoprevention agent for colorectal cancer. (2012) (12)
- Liquid diets for Crohn's disease (2001) (11)
- The clinical significance of antimicrobial serologic responses within an Irish Crohn’s disease population (2013) (11)
- Adherence to colorectal polyp surveillance guidelines: is there a ‘scope’ to increase the opportunities for screening? (2011) (11)
- Risk factors in inflammatory bowel disease. (1989) (11)
- Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort (2008) (10)
- THE MAASTRICHT GUIDELINES AND OTHER INNOVATIONS (1997) (10)
- Culture of the organisms and histochemical identification. (1988) (10)
- Increased inos and nitrotyrosine expression in irritable bowel syndrome (IBS) (2000) (10)
- The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients. (2019) (10)
- The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening. (2016) (10)
- Moving forward from drug-centred to patient-centred research (2019) (10)
- Improving surveillance for Barrett's oesophagus (2006) (10)
- Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection. (1999) (10)
- European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain (2020) (10)
- Immunochemical faecal occult blood tests have superior stability and analytical performance characteristics over guaiac-based tests in a controlled in vitro study (2011) (10)
- The burden of digestive disease across Europe: Facts and policies. (2019) (10)
- The safety and efficacy of tripotassium dicitrato bismuthate (De‐Nol) maintenance therapy in patients with duodenal ulceration (1990) (10)
- RIP2 polymorphisms in inflammatory bowel diseases. (2011) (9)
- Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force (2020) (9)
- Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis. (2009) (9)
- 15th United European Gastroenterology Week (2007) (9)
- Nutritional treatments in inflammatory bowel disease (2001) (9)
- Motion--Helicobacter pylori worsens GERD: arguments for the motion. (2002) (9)
- Validation of serological tests forHelicobacter pylori infection in an Irish population (2000) (9)
- Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study (2010) (9)
- Identification of a new segment involved in cagA 3' region variation of Helicobacter pylori. (2002) (9)
- The effects of blood on rapid urease testing forHelicobacter pylori in mucosal biopsies from the gastric antrum (2000) (8)
- Assessment of the clinical significance of intestinal spirochaetosis (2008) (8)
- Helicobacter pylori-induced duodenal ulcer frequently coincides with gastro-oesophageal reflux disease. (2002) (8)
- Clinical and pathological implications of IgG antibody responses toHelicobacter pyloriand its virulence factors in non‐ulcer dyspepsia (2003) (8)
- Detection of Phospholipases and Cytotoxic Activities of Helicobacter pylori (1993) (8)
- Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) (2022) (8)
- Non‐steroidal anti‐inflammatory drugs and Helicobacter pylori (2000) (8)
- Risk of adenomatous polyps and colorectal cancer in relation to serum antioxidants and cholesterol status (1991) (8)
- Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study. (2021) (8)
- Non-disease related factors affecting health related quality of life (HRQOL) in inflammatory bowel disease (IBD)* (1998) (8)
- Eosinophilic oesophagitis: an Irish experience (2011) (7)
- Do non‐steroidal anti‐inflammatory drugs have an effect on gastric cell turnover? (1995) (7)
- Test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention? (2003) (7)
- Effectiveness of Antiinfectives (2005) (7)
- European initiatives in colorectal cancer screening (2011) (7)
- The problem ulcer: bleeding, perforation, Helicobacter pylori -negativity and intractability (1996) (7)
- Nutritional therapy in ambulatory patients (1987) (7)
- A descriptive follow-up study onHelicobacter pylori infection before and after exposition to a war area (1994) (7)
- Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat? (2001) (7)
- Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori (1990) (7)
- Elemental diets and Crohn's disease. (1987) (7)
- Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? More studies should have been included in meta-analysis. (2000) (7)
- Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii (2018) (7)
- Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases (2022) (6)
- [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan]. (2020) (6)
- Recurrence of hepatic amebiasis after successful treatment with metronidazole. (1988) (6)
- Gastric retention and wireless capsule endoscopy in adults: a modified technique for direct duodenal deployment (2010) (6)
- European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia. (2018) (6)
- [Comparative study of the primary lactase deficiency in two different adult populations (55 inhabitants of Nice and 55 Maghrebins) (author's transl)]. (1978) (6)
- Food intolerance: Dietary treatments in functional bowel disorders (2003) (6)
- 5-Aminosalicylates in inflammatory bowel: disease: Choosing choosing the right dose (2001) (6)
- Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection. (1995) (6)
- Panel Discussion – Unresolved Issues (2000) (6)
- H. pylori in asymptomatic people (1994) (6)
- Computer-Assisted Propofol Administration (2010) (6)
- Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. (1999) (6)
- The effect of colonic site of biopsy on cell proliferation profiles using BRDU incorporation as a measure of cell proliferation. (1992) (5)
- Increased mucosal mast cells in irritable bowel syndrome (IBS) (1998) (5)
- Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis (2003) (5)
- Fundic gland polyps: not so trivial entity and worth evaluation. (2004) (5)
- Review article: non-steroidal anti-inflammatory drugs and Helicobacter pylori. (2000) (5)
- Evaluation of different solid media used for cultivation of Helicobacter (Campylobacter) pylori. (1992) (5)
- Helicobacter pylori Treatment Failure: The Rationale for Alternative Antibiotics (2016) (5)
- Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body (2020) (5)
- Reversible male infertility induced by sulphasalazine (1985) (5)
- Reinfection with Helicobacter pylori Due to Intrafamilial Clustering of the Organism (1993) (5)
- Early Epithelial Lesions in Crohn’s Disease, Revealed by Electron Microscopy (1981) (5)
- Early ultrastructural changes of antral mucosa with aspirin in the absence of Helicobacter pylori. (1995) (4)
- Di V erent management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease ? (1998) (4)
- Tu1328 Pan-European Registry on H. pylori Management (HP-EuReg): Interim Analysis of First- and Second-Line Treatments (2016) (4)
- Su1133 Pan-European Registry on H. pylori Management (HP-EuReg): Bacterial Resistance (2015) (4)
- Diet and Crohn's disease. (1987) (4)
- Increased iNOS expression in irritable bowel syndrome (IBS) patients with stress related symptoms (2003) (4)
- Altered cardia epithelial cell kinetics induced by Helicobacter pylori infection and gastro‐oesophageal reflux disease: possible malignant potential? (2003) (4)
- Molecular Detection of Antibiotic-Resistant Helicobacter pylori. (2021) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- Nutritional support in Crohn's disease: current status and future directions. (1995) (4)
- Population characteristics of IrishHelicobacter pylori isolates: a tRNA-associated locus (2000) (4)
- M1115 Sequential Therapy for Helicobacter pylori Eradication: A Critical Review (2010) (4)
- The use of cyclosporin in the management of acute exacerbations of inflammatory bowel disease (1995) (4)
- Irish society of gastroenterology (1991) (4)
- Ornithine decarboxylase G316A genotype and colorectal cancer risk (2011) (4)
- Association of reactive arthropathy and Morganella morganii cross reacting with Yersinia enterocolitica. (1988) (4)
- Problems which address health related quality of life (HRQOL) in inflammatory bowel disease (IBD) (1998) (4)
- Crohn's Disease Treated by Elemental Diet (1982) (4)
- Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg) (2022) (4)
- A case of achalasia diagnosed first on capsule endoscopy: find that hard to swallow? (2010) (3)
- Helicobacter Pylori eradication therapy: getting research into practice. (2003) (3)
- Re: Herrlinger et al.—pulmonary function abnormalities in inflammatory bowel disease (2002) (3)
- "Best practice' for Helicobacter pylori eradication in the primary care setting. (2006) (3)
- [Pan-European Registry on Helicobacter pylori management. Results from Ferencváros, Budapest, 2013-2019]. (2019) (3)
- Endoscopic surveillance of premalignant gastric lesions (2003) (3)
- Aminosalicylate as prophylaxis for Crohn's disease (2001) (3)
- Temporomandibular joint dislocation: an unusual complication of upper gastrointestinal endoscopy. (2000) (3)
- Novel therapeutic approaches to the management of Helicobacter pylori infection. (1998) (3)
- Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
- Adult Lead Toxicity and Untreated Coeliac Disease (1988) (3)
- Sa1256 Cost-Effectiveness of Episodic or Maintenance Infliximab Treatment Versus Standard Treatment in a Community-Based Incidence Cohort of Adult Ulcerative Colitis Patients With 10-Years Follow-up (2012) (3)
- European Registry on Helicobacter pylori management (Hp-EuReg): First-line Therapy in Israel. (2021) (2)
- How to Eradicate Helicobacter pylori and Prevent Reinfection (1990) (2)
- Consensus Report Helicobacter pylori infection - The Maastricht III Current concepts in the management of (2007) (2)
- Colonoscopy completion rates--are we prepared for a national screening programme? (2007) (2)
- Salicylates, steroids and immnunosuppressants in Crohn's disease : Management of Crohn's disease (1994) (2)
- Helicobacter pylori infection and gastric cancer: usefulness of screening high risk groups. (1995) (2)
- : the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease (2015) (2)
- Gastric Polyps – Frequency,Types, Endoscopic Features and Associations (2004) (2)
- W1312 Long Term Efficacy of the Second Biologic in the Management of Crohn's Disease. A Retrospective Survey on an English- Irish Cohort (2010) (2)
- Concept of chemoprevention in colorectal cancer. (2009) (2)
- P597 Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure (2018) (2)
- Antibiotic resistance trends of Helicobacter pylori naïve patients in the period 2013-2019: Analysis of the European Registry on H. pylori Management (Hp-Eu- Reg) (2020) (2)
- Treatment of Helicobacter pylori infection (2003) (2)
- Validation of Capsule Endoscopy Crohn's Disease Activity Score (CECDAI or Niv Score) – A Multi Center Prospective Study (2011) (2)
- Living related liver transplantation : a Japanese experience and development of a checklist for donors ’ informed consent (2002) (2)
- H. pylori eradication therapy: A discrepancy between current guidelines and clinical practice (1998) (2)
- Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management (2020) (2)
- Treatment of Helicobacter pylori (1998) (2)
- Su1145 Detection of Helicobacter pylori and Antibiotic Resistance Using a Molecular Genetics-Based Approach in Human Faecal Samples (2015) (2)
- A genetic locus of Helicobacter pylori inversely associated with gastric intestinal metaplasia. (2005) (2)
- Challenges and Opportunities in IBD Clinical Trial Design. (2021) (2)
- Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel (2016) (2)
- Crohn's Disease: Treatment and Pathogenesis (1987) (2)
- THE ROLE OF RIFAXIMIN IN IRRITABLE BOWEL SYNDROME DERIVED FROM A NETWORK META-ANALYSIS OF RANDOMIZED CONTROL TRIALS (2020) (2)
- Nutrition and Crohn's Disease: An Overview (1990) (2)
- Drug treatment of eosinophilic oesophagitis. (2012) (2)
- The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg) (2021) (2)
- Combined antrum and corpus biopsy protocol improves Helicobacter pylori culture success (2022) (2)
- Empirical Second-Line Treatments in Europe: Results from the European Registry on H. Pylori Management (Hp-EuReg) (2021) (1)
- Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease (2020) (1)
- Tolerability of Shortened Infliximab Infusion in Scheduled Maintenance Therapy for IBD: A Prospective Multi-center European Cohort Study (2013) (1)
- ERADICATION RATE OF HELICOBACTER PYLORI. AUTHORS' REPLY (1995) (1)
- Predicting Screening Uptake by First‐Degree Relatives of Patients Diagnosed with Colorectal Cancer1 (2012) (1)
- P254 Effect of standard treatment (ST) versus episodic (ET) or maintenance (MT) infliximab on healthcare cost (HC) and quality-adjusted life years (QALYs) in a community-based incidence cohort of adult Crohn's disease patients with 10 years follow-up (2012) (1)
- IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. (2022) (1)
- Treatment of Helicobacter pylori Infection (2006) (1)
- Letter: the ethics of using inferior regimens in H. pylori randomised trials – invited comment (2012) (1)
- Isolated Active Ileitis: Serological and Genetic Profile (2011) (1)
- Su1135 Pan-European Registry on H. pylori Management (HP-EuReg): Rescue Treatments (2015) (1)
- An Audit of the Biopsy Protocol for Barretts Eosophagus – Need to Improve Compliance to Guidelines? (2004) (1)
- Host cytokine responses toHelicobacter pylori: an important determinant of clinical outcome (2001) (1)
- 5-Aminosalicylates in inflammatory bowel disease: choosing the right dose. (2001) (1)
- Novel therapies for Helicobacter pylori eradication (1998) (1)
- 128 Use of a biochip assaying 28 mutations in the KRAS, BRAF, TP53, and APC genes for detection of colorectal neoplasia (2010) (1)
- Assessment of first-line eradication treatment in Greece: data from the European Registry on Helicobacter pylori management (Hp-EuReg) (2021) (1)
- Colorectal Malignancy in a Prospective Irish Inflammatory Bowel Disease Population 15 Years Since Diagnosis: Comparison with the EC-IBD Cohort (2017) (1)
- Educational needs in patients with irritable bowel syndrome (IBS): Implications for clinical management (1998) (1)
- Small Intestinal Permeability in Patients with Inflammatory Bowel Disease (1983) (1)
- Chromium-51-EDTA and technetium-99m-DTPA excretion for assessment of small bowel Crohn's disease (1984) (1)
- Tu1327 Pan-European Registry on H. pylori Management (Hp-EuReg): Interim Analysis of Non-Bismuth Quadruple Concomitant Treatment (2016) (1)
- Colonoscopy in Adults Younger Than 30 Years: A Blunt Instrument? (2009) (1)
- Hepatic haemangiosarcoma in a patient with psoriasis and Crohn’s disease (1992) (1)
- A new marker for colorectal cancer (2005) (1)
- Increased mucosal mast cells - Evidence of an inflammatory response in IBS? (1999) (1)
- Mo1580 Age, Smoking, Male Gender and Regular Aspirin use Predict Premalignant Conditions of the Stomach in a Low Gastric Cancer Prevalence Cohort (2012) (1)
- Attempts to Eradicate Campylobacter pylori — Irish Experiences (1988) (1)
- The role of defensive information processing in population‐based colorectal cancer screening uptake (2023) (1)
- Helicobacter pylori : Phospholipase C and Haemolysis (1994) (1)
- The Management of Duodenal Ulcer Relapse (1988) (1)
- Improving surveillance for Barrett's oesophagus: Better to be looked over than be overlooked (2006) (1)
- P641 Anxiety and depression in a prospective cohort of inflammatory bowel disease patients in Ireland (2014) (1)
- Adalimumab in the Management of Crohn's Disease (CD) Patients with a Loss of Response to Infliximab (2006) (1)
- 182 Test, Treat and Re-Test. Who is Best at Checking for Helicobacter pylori Eradication After Apositive Urea Breath Test (UBT), Family Physicians or Gastroenterologists? (2010) (1)
- OC-071 Comparison of Faecal M2-PK and Fit in Screening for Colonic Polyps in an average Risk Population (2013) (0)
- METRONIDAZOLE AFFECTS HELICOBACTER PYLORI RELATED NONULCER DYSPEPSIA AND SYMPTOMS FROM CARBOHYDRATE MALABSORPTION. AUTHOR'S REPLY (1995) (0)
- Rifabutin-Based Eradication Therapy after Failure of Standard First- and Second-Line Eradication Therapies in Helicobacter Pylori Infected Patients (2004) (0)
- P257 - Genetic association between Crohn's disease and a marker located in the region of claudin 2 implicates the intestinal barrier as a primary risk factor in a Swedish population (2009) (0)
- Activation of nuclear factor-kB (NF-kB) in diarrhoea predominant irritable bowel syndrome (2001) (0)
- The Year in Helicobacter 2007 (2007) (0)
- T1239 Infliximab in Inflammatory Bowel Disease: ‘Can We Heal Two Disease with One Drug?’ (2008) (0)
- Table of Contents (2006) (0)
- Polyp Surveillance - Experience from a Single Gastrointestinal Unit (2004) (0)
- TREATMENT OF HELICOBACTER PYLOR (1998) (0)
- M1102 ANCA, ASCA, Anti-OmpC and Anti-Cbir Antibodies Within An Irish Crohns Disease Cohort (2009) (0)
- Gastric urease and peptic ulcer disease in Ireland in the 1940s — The Fitzgerald connection (2002) (0)
- Eradication (1995) (0)
- OC.08.2 EFFECTIVENESS OF EMPIRICAL FIRST-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Retraction Statement. Paper by Iebba V, Aloi M, Civitelli F, Cucchiara S: Digestive Diseases 2011;29:531-539 (DOI: 10.1159/000332969) (2014) (0)
- Su1134 Pan-European Registry on H. pylori Management (HP-EuReg): Safety (2015) (0)
- The plasticity region locus JHP947 is a pathogenicity marker found in Helicobacter pylori-associated gastric intestinal metaplasia (2005) (0)
- Alpha 1 Anti Trypsin Levels in Asymptomatic Patients with Abnormal Liver Function Tests (2006) (0)
- “Test, treat and confirm eradication” (2017) (0)
- Dyspepsia: A test and treat management strategy (2001) (0)
- Tu1214 The High Frequency of Adenomas Detected on Screening in Older Patients Warrants the Inclusion of This Cohort in National Programmes (2012) (0)
- M1106 The Serological Profile of Isolated Active Ileitis (2009) (0)
- Protein malnutrition in inflammatory bowel disease – An unrecognised problem? (2005) (0)
- Endoscopy negative reflux: Any role for biopsy? (2000) (0)
- P007 Rates of lactose malabsorption amongst Irish Caucasian inflammatory bowel disease patients (2012) (0)
- Standards of colonoscopy in tallaght hospital; need for beyond the caecum (2006) (0)
- Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg) (2022) (0)
- The Bactericidal Effect of Tripotassium Dicitrato Bismuthate on Campylobacter Pyloridis in Patients with Duodenal Ulcer (1986) (0)
- Contents Vol. 93, 2016 (2016) (0)
- P401 Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease (2019) (0)
- Helicobacter pylori and Duodenal Ulcer (1993) (0)
- DISEASE CARD 4 / NOD 1 is not involved in inflammatory bowel disease (2002) (0)
- Identification of differentially expressed genes of Heucobacter pylori in response to prolonged acid exposure (2000) (0)
- P704 Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease (2019) (0)
- web-guided ' Constant-care ' approach colitis : a randomised controlled trial of the E-health empowers patients with ulcerative (0)
- Erratum: The microbiota in inflammatory bowel disease in different age groups (Digestive Diseases (2009) 27 (252-258) DOI: 10.1159/000228558) (2014) (0)
- Changing Prevalence of Helicobacter pylori Infection in Elderly Dyspeptic Patients (2006) (0)
- Helicobacter pylori infection. Implications for ulcer therapy in older patients. (1994) (0)
- Increased inflammatory mediators in irritable bowel syndrome (IBS) (2005) (0)
- Carditis: All H.pylori or an association with GERD? (2000) (0)
- Stool DNA Testing – Not Quite There Yet? (2006) (0)
- United European Gastroenterology Federation (2003) (0)
- Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: results of a multidisciplinary international expert panel (EPACT II) (2009) (0)
- Helicobacter pylori and gastric cancer. (1995) (0)
- European Registry on Helicobacter pylori Management (Hp-EuReg): Most relevant results for clinical practice (2022) (0)
- M1140 Helicobacter pylori Eradication Treatment is More Successful When Diagnosis is Made After Urea Breath Test Than After Rapid Urease Testing at Endoscopy in Patients With Dyspepsia (2010) (0)
- United European Gastroenterology joins the Biomedical Alliance for Health Research (2014) (0)
- 178 Changing Patterns of Clarithromycin and Metronidazole Resistance Amongst Helicobacter pylori Strains in a Reference Centre (2010) (0)
- Mucosal Enzyme Abnormalities in Rectal Biopsy in Inflammatory Bowel Disease (1982) (0)
- OC.08.4 ANTIBIOTIC RESISTANCE TRENDS OF ITALIAN H. PYLORI NAÏVE PATIENTS BETWEEN 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- 685 Longitudinal Changes in Body Mass Index and Abdominal Obesity in Crohn's Disease - Associations With Inflammatory Markers and Disease Course (2013) (0)
- Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) (2022) (0)
- Eradication of Helicobacter pylori: Summary of Workshop (1993) (0)
- Adenomatous polyps and colorectal cancer in relation to serum vitamin E and related antioxidants (1990) (0)
- P109 CIGARETTE SMOKING, DISEASE LOCATION AND SEVERITY IN CROHN'S DISEASE (2008) (0)
- Patients with Azathioprine/6-Mercaptopurine Refractory Inflammatory Bowel Disease are more prone to 6-Thioguanine Related Toxicity (2004) (0)
- Tu1335 European Registry on H. pylori Management (HP-EuReg) in Spain: Interim Analysis in First and Second Line Therapies (2016) (0)
- Absolute leukocyte count and its correlation with thiopurine methyl transferase (TPMT) activity in inflammatory bowel disease (IBD) patients receiving AZAthioprine (Aza)/6-mercaptopurine (6MP) (2003) (0)
- The role of nutrition in liver disease. (1996) (0)
- Research on digestive and liver diseases: a priority for Europe – The societal importance of gastrointestinal diseases and research (2013) (0)
- Issue Information – TOC ‐ Masthead (2016) (0)
- Diversity of the cag7 and cag2 genes in H. pylori (2001) (0)
- SNP mapping of the HLA class III region confirms existence of an extended haplotype in coeliac disease (2003) (0)
- Metronidazole affectsHelicobacter pylori related nonulcer dyspepsia and symptoms from carbohydrate malabsorption (1995) (0)
- AF.24 CHARACTERISTICS OF EMPIRICAL FIRST- AND SECOND-LINE TREATMENT BETWEEN 2013-2020: ITALIAN DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Correlation between severity of villous atrophy and gastric mucosal inflammation — an observational case control study (2003) (0)
- OC.08.5 EFFECTIVENESS OF EMPIRICAL SECOND-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Re: Scolapio et al.--Normal endoscopy, dysphagia, and esophageal dilation. (2001) (0)
- 63 10 year follow-up study of the long term effects of ANTI-TNF therapyon bone metabolism in a cohort of ANTI-TNF naïve IBD patients (2017) (0)
- ULCERATIVE colitis and pregnancy. (2011) (0)
- carcinoma . progression from normal mucosa to gastric Gastric epithelial cell kinetics in the (2006) (0)
- PGI10 COST EFFECTIVENESS OF PROTON PUMP INHIBITOR TRIPLE THERAPY REGIMENS FOR HELICOBACTER PYLORI ERADICATION IN THE PRIMARY CARE SETTING IN IRELAND (2005) (0)
- inflammatory bowel disease . biopsies from patients with immunocytochemical studies in rectal concentrations and Vasoactive intestinal peptide (2006) (0)
- S1187 Genetic Association Between Crohn's Disease and a Marker Located in the Region of Claudin 2 Implicates the Intestinal Barrier As a Primary Risk Factor in a Swedish Population (2009) (0)
- P216 IBD Patients' Need in Quality of Health Care (QoHC) ECCO Consensus (2008) (0)
- Helicobacter pylori eradication for dyspepsia is clinically useful (2000) (0)
- CARD4/NOD1 in inflammatory bowel disease. (2002) (0)
- "This is the pre-peer reviewed version of the following article: Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel (2015) (0)
- 60 Tailored therapy for rescue treatment of helicobacter pylori infection (2017) (0)
- Activation of nuclear factor-kappa B (NF-kappa B)in diarrhoea predominant irritable bowel syndrome (2001) (0)
- Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management (2022) (0)
- Elemental Diet in the Treatment of Inflammatory Bowel Disease (2018) (0)
- Prevalence of Helicobacter pylori: An Irish Experience in a Dublin Associated Teaching Hospital over a Six Year Period (2006) (0)
- Prevalence and Evolution of Hypertransaminasemia in the Newly Diagnosed Coeliac Patients: An Irish Experience in a Dublin Hospital (2006) (0)
- Helicobacter pyloni (0)
- Clinical Application of Antibiotics in Eradicating Helicobacter pylori (1994) (0)
- Re: Herrlinger et al.--Pulmonary function abnormalities in inflammatory bowel disease. (2002) (0)
- 309 Prevalence of Hypertension in a Hereditary Haemachromatosis Population and the Influence of Treatment on Their Cardiovascular Risk (2010) (0)
- A Descriptive Study of the Characteristics of People with Helicobacter pylori Infection (1993) (0)
- P244 15 Years on: The Outcome of the Irish EC-IBD Cohort (2008) (0)
- Multiple organ dysfunction following ingestion of methylenedioxy-amphetamine (MDA) (1995) (0)
- P463 Long-term effects of anti-TNF therapy on bone metabolism (2018) (0)
- Introduction from the President (2013) (0)
- Sulfasalazine: Side effects (1984) (0)
- EP1019: THE EFFECTS OF THE COVID-19 PANDEMIC ON PRESENTATIONS AND DIAGNOSIS OF UPPER GI AND HEPATOPANCREATICOBILIARY MALIGNANCIES (2022) (0)
- Su1136 Pan-European Registry on H. pylori Management (HP-EuReg): Interim Analysis of 8,271 Patients (2015) (0)
- Distribution of polyps and cancer in the colon (2005) (0)
- Localization of HLA and IA Antigens and β2 Microglobulins in Human Small Intestinal Mucosal Cells (1983) (0)
- Management of Helicobacter pylori infection — a review of the available regional and national guidelines (2003) (0)
- [When should Helicobacter pylori be eradicated?]. (1994) (0)
- Undernutrition and Reduced Muscle Funcion Is Common in Young Patients with Crohns Disease (Cd) (2006) (0)
- Current trends in the treatment of H. pylori infection in Ukraine: results of the European Registry on Helicobacter pylori Management (Hp EuReg) (2022) (0)
- Detection of premalignant lesions in first degree relatives of gastric cancer: Endoscopy or serodiagnosis? (2003) (0)
- Multiple drug resistance gene (MDRI) polymorphisms and steroid resistance in inflammatory bowel disease (IBD) (2003) (0)
- Investigations of Asymptomatic Patients with Abnormal Liver Function Tests (LFT's) in the Outpatient Setting. Experience and Cost Analysis in the Real World (2006) (0)
- Are we able to treat inflammatory bowel disease with diet (2005) (0)
- Il-1b polymophisms are NOT associated with Helicobacter pylori positive intestinal metaplasia (2003) (0)
- T2069 Effects of Tryptase and Mast Cells on Intestinal Permeability and Tight Junction Proteins: Implications for the Pathogenesis for Irritable Bowel Syndrome (IBS) (2010) (0)
- Infliximab in Patients with Moderate to Severe Ulcerative Colitis with a Failed Response to Medical Therapy (2006) (0)
- Eradication rate of Helicobcter pylori. (1995) (0)
- Le cancer gastrique : une conséquence à long terme de l'infection à Helicobacter pylori ? (1994) (0)
- Retraction Statement. Paper by Krznarić Ž, Vranešić Bender D, Kunović A, Kekez D, Štimac D: Digestive Diseases 2012;30:196-200 (DOI: 10.1159/000336965) (2014) (0)
- Helicobacter pylori infection and gastric cancer (2005) (0)
- Dyspepsia Prescribing by Primary Care Physicians (PCPS) – The Impact of an Open Access Urea Breath Test Service (2004) (0)
- A proposal for future Helicobacter pylori eradication guidelines (2003) (0)
- The Effect of Eicosapentaenoic Acid on Treatment and Neutrophil Function in Inflammatory Bowel Disease (1986) (0)
- Innovations in Gastro-Intestinal Endoscopy: Endoscopic Antireflux Therapies for Gastro-Oesophageal Reflux Disease (2003) (0)
- W1882 Identification of Smoking As a Risk Factor for Gastric Intestinal Metaplasia (2008) (0)
- Investigations into substance P and mast cells in functional dyspepsia (2001) (0)
- Re: Scolapio et al.—normal endoscopy, dysphagia, and esophageal dilation (2001) (0)
- Introduction (2003) (0)
- 154 Significant Psychological Co-Morbidity Exists in Irritable Bowel Syndrome: A Case-Control Study Using the Irish Hse-Pcrs Pharmacy Reimbursement Database (2008) (0)
- P076 Role of Increasing Body Mass Index in Adults with Quiescent Crohn's Disease (2008) (0)
- P594 Ustekinumab treatment effectiveness in clinical practice - a multicentre retrospective review of long-term outcomes in Crohn's disease. (2017) (0)
- High Prevalence of Vitamin D Insufficiency in Inactive Crohn's Disease (CD) (2006) (0)
- helicobacter pylori cagA, cagE and BabA2 genotypes in patients with intestinal metaplasia and gastritis (2006) (0)
- PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over Time (2012) (0)
- P042 High Prevalence of Vitamin D Deficiency in Crohn's Disease in Wintertime: Spectrum of a Wider Public Health Problem? (2008) (0)
- Virulence factors predict long-term clinical efficacy of eradication therapy in nonulcer dyspepsia (NUD) (2000) (0)
- Calcium intake in crohn's disease (CD): Are we meeting the nutritional guidelines? (2005) (0)
- Prevalence of overweight and obesity in patients with Crohn's disease in Western countries and Japan (2013) (0)
- Introduction (2003) (0)
- Screening for colorectal cancer (2007) (0)
- Helicobacter pylori . mucosa with aspirin in the absence of Early ultrastructural changes of antral (0)
- Sa1570 Barrett's Metaplasia: Underdiagnosed At Endoscopy (2011) (0)
This paper list is powered by the following services: